Fulgent Genetics, Inc. (FLGT) has a consensus analyst rating of Buy, based on 9 analysts covering the stock. Of those, 6 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for FLGT is $36.00, representing a +122.6% upside from the current price of $16.17. Price targets range from a low of $36.00 to a high of $36.00.
